-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MYsXML4tnv6nm6zmAF2H2ILNjqvmad/Aeo6MDgjvIolSXbKNNlM714H1InJeea97 PFFLHsKjo19EsSf81DVFyg== 0000950130-97-000563.txt : 19970222 0000950130-97-000563.hdr.sgml : 19970222 ACCESSION NUMBER: 0000950130-97-000563 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970213 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: ROBERTS PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0000853022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222429994 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-13729 FILM NUMBER: 97531430 BUSINESS ADDRESS: STREET 1: MERIDIAN CENTRE II STREET 2: 4 INDUSTRIAL WAY W CITY: EATONTOWN STATE: NJ ZIP: 07724 BUSINESS PHONE: 9083891182 MAIL ADDRESS: STREET 1: MERIDIAN CTR II STREET 2: 4 INDUSTRIAL WAY WEST CITY: EATONTOWN STATE: NJ ZIP: 07724 424B3 1 SECOND SUPPLEMENT TO PROSPECTUS Registration No. 333-13729 Rule 424(b)(3) ROBERTS PHARMACEUTICAL CORPORATION Second Supplement to Prospectus Dated November 7, 1996 The following information amends and supplements the information set forth in the Prospectus of Roberts Pharmaceutical Corporation dated November 7, 1996. Capitalized terms used herein, unless otherwise defined, have the meanings ascribed to them in the Prospectus. SELLING SHAREHOLDERS The Company has been advised that Overlook Performance Fund has transferred 80,000 shares of Convertible Preferred Stock to Highbridge Capital Corporation, and Chestnut Pacific Fund, the & Trust, Standard Global Equity Partners, L.P., the Common Fund, Scorpion Offshore Investment Fund and Standard Pacific Capital Offshore Fund, Ltd. have transferred an aggregate of 80,000 shares of Convertible Preferred Stock to Global Bermuda L.P., Lakeshore International Ltd. and Merced Partners, L.P. As a result of such transactions, the information set forth in the table presented under "Selling Shareholders" in the Prospectus is hereby amended (with respect to certain entities that have transferred the Convertible Preferred Stock) and supplemented (to add information pertaining to the entities that have acquired the Convertible Preferred Stock) as follows:
Beneficial Ownership Number of Shares Beneficial Ownership of Common Stock of Common Stock of Common Stock Name of Selling Shareholders Prior to Offering (1) Being Offered After Offering (1) - ---------------------------- --------------------- ---------------- ---------------------- Number of Percent Number of Percent of Shares of Class Shares Class --------- -------- --------- --------- Chestnut Pacific Fund................. 13,604 (3) 13,604 -0- -0- The & Trust........................... 6,291 (3) 6,291 -0- -0- Standard Global Equity Partners, L.P. ..................... 34,156 (3) 34,156 -0- -0- The Common Fund....................... 8,829 (3) 8,829 -0- -0- Scorpion Offshore Investment Fund..... 100,846 (3) 100,846 -0- -0- Standard Pacific Capital Offshore Fund, Ltd.................. 10,072 (3) 10,072 -0- -0- Overlook Performance Fund............. 86,899 (3) 86,899 -0- -0- Global Bermuda LP..................... 86,899 (3) 86,899 -0- -0- Lakeshore International Ltd........... 43,450 (3) 43,450 -0- -0- Merced Partners....................... 43,450 (3) 43,450 -0- -0- Highbridge Capital Corporation........ 173,747 (3) 173,747 -0- -0-
The footnotes to the table presented above correspond to the footnotes to the table presented under "Selling Shareholders" in the Prospectus. The information set forth above does not reflect sales of Common Stock that may have been effected by Selling Shareholders since November 7, 1996. February 13, 1997
-----END PRIVACY-ENHANCED MESSAGE-----